2026 NPPES data Otolaryngic Allergy Physician NPI 1396731402 M.D.
Verify on CMS →

RAVI PACHIGOLLA, M.D.

Otolaryngic Allergy Physician in WEATHERFORD, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
652
Medicare Part D claims · 264 beneficiaries · Otolaryngic Allergy Physician avg: 788
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$895
21 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: RAVI PACHIGOLLA, M.D. is a Otolaryngic Allergy Physician ([object Object]) practicing in WEATHERFORD, Texas with a Medicare Part D prescribing footprint of 652 claims across 264 beneficiaries — 14% brand-name prescribing . Their CMS MIPS Final Score of 0/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $895 across 21 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

RAVI PACHIGOLLA, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 652 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
652
Part D claims, 2023
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RAVI PACHIGOLLA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RAVI PACHIGOLLA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

RAVI PACHIGOLLA, M.D. at a glance

Below national average

NPI registry status

Active

Issued 09/23/2005

NPI 1396731402

Primary specialty

Otolaryngic Allergy Physician

Rare

151 US NPIs in this specialty

Medicare Part D claims

652 17% vs specialty avg

2023 prescription claims

Specialty avg: 788

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Texas

How Otolaryngic Allergy Physician compares to other specialties among Texas providers

Texas providers

Otolaryngic Allergy Physician share within Texas

1. Otolaryngic Allergy Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngic Allergy Physician share within Texas

Medicare quality performance — MIPS

RAVI PACHIGOLLA, M.D.'s 2023 MIPS final score plotted against the Otolaryngic Allergy Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngic Allergy Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Otolaryngic Allergy Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RAVI PACHIGOLLA, M.D. is a Otolaryngic Allergy Physician provider practicing in WEATHERFORD, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1396731402. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

RAVI PACHIGOLLA, M.D. appears in the CMS NPPES registry as a Otolaryngic Allergy Physician provider holding M.D. credentials at 2016 FORT WORTH HWY, WEATHERFORD, TX, 76086, with a listed phone of (817) 596-8637. NPI 1396731402 was issued on 09/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PACHIGOLLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 652 prescription claims written by this provider, covering 264 Medicare beneficiaries and totaling roughly $26K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 4.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Otolaryngic Allergy Physician is a narrow specialty nationwide, with 151 enrolled providers across 38 states and an average of 788 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2016 FORT WORTH HWY
WEATHERFORD, TX 76086

Provider Details

NPI 1396731402
Specialty Otolaryngic Allergy Physician
Credentials M.D.
Gender Male
NPI Issued 09/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RAVI PACHIGOLLA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$895

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to RAVI PACHIGOLLA, M.D.. To verify RAVI PACHIGOLLA, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

RAVI PACHIGOLLA, M.D. — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 652 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

652
Total Claims
$26K
Total Drug Cost
264
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
807
Total Day Supply
16,937
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$8K
Generic Drug Cost
$18K
Opioid Claims
28 (4.3% rate)
Antibiotic Claims
120

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.21
Gender Split
55% female / 45% male
Age Distribution
<65: 37, 65-74: 111, 75-84: 98, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ipratropium Bromide
201
Azelastine Hcl
52
Montelukast Sodium
47
Ciprofloxacin Hcl
41
Cephalexin
40
Prednisolone Acetate
37
Clindamycin Hcl
35
Epinephrine
31
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
27
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngic Allergy Physician Overview

How RAVI PACHIGOLLA, M.D. fits within the Otolaryngic Allergy Physician landscape nationally.

151
Otolaryngic Allergy Physician Providers in US
38
States with Otolaryngic Allergy Physician
788
Avg Claims per Provider

RAVI PACHIGOLLA, M.D.'s 652 claims are below the specialty average of 788.

Nearby Otolaryngic Allergy Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as PACHIGOLLA.

Compare Otolaryngic Allergy Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RAVI PACHIGOLLA, M.D.'s specialty?
RAVI PACHIGOLLA, M.D. specializes in Otolaryngic Allergy Physician and practices in WEATHERFORD, Texas. Credentials: M.D..
How much does RAVI PACHIGOLLA, M.D. prescribe under Medicare Part D?
In 2023, RAVI PACHIGOLLA, M.D. wrote 652 Medicare Part D claims totaling $26K in drug costs for 264 beneficiaries.
What is RAVI PACHIGOLLA, M.D.'s Medicare quality score?
RAVI PACHIGOLLA, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RAVI PACHIGOLLA, M.D. located?
RAVI PACHIGOLLA, M.D. is located at 2016 FORT WORTH HWY, WEATHERFORD, TX, 76086. Phone: (817) 596-8637.
What is RAVI PACHIGOLLA, M.D.'s NPI number?
RAVI PACHIGOLLA, M.D.'s National Provider Identifier (NPI) is 1396731402, issued on 09/23/2005.
Does RAVI PACHIGOLLA, M.D. prescribe more brand-name or generic drugs?
RAVI PACHIGOLLA, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $8K in brand drug costs.
Does RAVI PACHIGOLLA, M.D. prescribe opioids?
Yes, RAVI PACHIGOLLA, M.D. had 28 opioid claims in 2023 with an opioid prescribing rate of 4.3%.
How many Otolaryngic Allergy Physician providers are there in the US?
There are 151 Otolaryngic Allergy Physician providers across 38 states in the US. The average Otolaryngic Allergy Physician provider writes 788 Medicare Part D claims per year.
What drugs does RAVI PACHIGOLLA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RAVI PACHIGOLLA, M.D.'s most frequently prescribed drugs include Ipratropium Bromide, Azelastine Hcl, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RAVI PACHIGOLLA, M.D. accept Medicare?
RAVI PACHIGOLLA, M.D. appears in CMS Medicare data with 652 Part D claims and 264 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RAVI PACHIGOLLA, M.D.'s credentials?
RAVI PACHIGOLLA, M.D.'s NPI is 1396731402 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology